![Francis McCormick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francis McCormick
Fondateur chez
BRIDGEBIO PHARMA, INC.
Fortune : 61 M $ au 31/07/2026
Profil
Francis Patrick McCormick is the founder of BridgeBio Pharma LLC, founded in 2015.
Dr. McCormick was the founder of Onyx Pharmaceuticals, Inc., founded in 1992, and served as Chief Scientific Officer from 1992 to 1996.
Dr. McCormick was the founder of Avidity Biosciences, Inc., founded in 2012, and served as Director.
Dr. McCormick is the founder of BridgeBio Pharma, Inc., founded in 2015, and holds the title Director & Chairman-Oncology since 2023.
Dr. McCormick is also the founder of DNAtrix, Inc...
Dr. McCormick currently serves as Director at PellePharm, Inc., Arresto BioSciences, Inc., Melanoma Therapeutics Foundation, Navire Pharma, Inc., and holds the position of Independent Director at Bridgebio Oncology Therapeutics, Inc. Dr. McCormick is Director at UCSF Helen Diller Family Comprehensive Cancer Center since 1997.
Dr. McCormick is a Member of the National Academy of Sciences since 2014.
Former positions include Independent Director at Exelixis, Inc. from 2011 to 2014, Independent Director at Aduro BioTech, Inc. from 2010 to 2019, Director at Peloton Therapeutics, Inc., Independent Director at Olema Pharmaceuticals, Inc. from 2014 to 2021, Vice President-Research at Chiron Corp.
from 1991 to 1992, Vice President-Discovery Research at Cetus Corp.
from 1991 to 1992, President of the American Association for Cancer Research in 2013, and Associate Dean at UCSF School of Medicine from 1997 to 2014.
Education includes a doctorate from the University of Cambridge conferred in 1975 and an undergraduate degree from the University of Birmingham conferred in 1972.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BRIDGEBIO PHARMA, INC. 0,39 % | 22/06/2026 | 767 244 ( 0,39 % ) | 61 M $ | 31/07/2026 |
-.--% | 16/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Francis McCormick
| Sociétés | Poste | Début |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Fondateur | 01/01/2015 |
UCSF Helen Diller Family Comprehensive Cancer Center
 UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/1997 |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Directeur/Membre du Conseil | - |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Directeur/Membre du Conseil | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | 01/01/2014 |
Melanoma Therapeutics Foundation
 Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Supports and researches treatments for melanoma | Directeur/Membre du Conseil | 28/06/2011 |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines to treat cancer and fibrotic diseases | Directeur/Membre du Conseil | 13/08/2009 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Fondateur | 16/02/2010 |
Anciens postes connus de Francis McCormick
| Sociétés | Poste | Fin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/04/2021 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Francis McCormick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
PellePharm, Inc.
PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines to treat cancer and fibrotic diseases | Commercial Services |
Melanoma Therapeutics Foundation
Melanoma Therapeutics Foundation Miscellaneous Commercial ServicesCommercial Services Supports and researches treatments for melanoma | Commercial Services |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology Discovers and develops medicines for patients with genetic diseases | Health Technology |
Navire Pharma, Inc.
Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
